Target intelligence / Profile preview

RN7SK pseudogene 109 (RN7SKP109)

Target
RN7SKP109
Molecular classification
Other, Pseudogene
01

Overview

RN7SK pseudogene 109 (abbreviated RN7SKP109) is classified as a pseudogene of the RN7SK small nuclear RNA gene[3]. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional; they do not produce functional protein or RNA product and are not involved in normal biological processes or drug targeting. RN7SKP109 is considered a non-coding RNA pseudogene and has no known therapeutic or biological role, nor is it implicated as a receptor, enzyme, transporter, or transcription factor[3]. Note: - The functional and biologically relevant gene is RN7SK, which plays a key role in transcription regulation, but RN7SKP109 is a presumed nonfunctional copy (pseudogene), not a true target, and has no known association with human disease, molecular function, or drug interaction[1][3]. - The entries conflating RN7SK with RN7SKP109 are incorrect for therapeutic or mechanistic relevance[1][3]. In summary: RN7SKP109 should not be considered a drug target or biologically functional molecule; it is a pseudogene with no established biological activity, function, or therapeutic implications[3].

Other names
RNA, 7SK small nuclear pseudogene 109RN7SKP109
02

Mechanism of action

None

03

Biological functions

None established (pseudogene)
04

Disease associations

None established

Beyond the preview

Go deeper on RN7SK pseudogene 109 (RN7SKP109).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 109 (RN7SKP109).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call